Terms: = Germ cell tumor AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Prognosis
164 results:
1. [neuroendocrine Carcinoma of the Non-Ampullary Duodenum-A Case Report].
Tsukamoto T; Edagawa E; Togano S; Hori T; Tsujio G; Kunimoto T; Kaizaki R; Inoue T; Takatsuka S; Fukushima H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1700-1702. PubMed ID: 38303178
[TBL] [Abstract] [Full Text] [Related]
2. The Association of Melanoma-Associated Antigen-C Gene With Clinicopathological Characteristics and prognosis in Breast Cancer: A Systematic Review and Meta-Analysis.
Lin X; Huo J; Su H; Xu Y; Zhang F
Clin Breast Cancer; 2024 Jan; 24(1):7-16. PubMed ID: 37872029
[TBL] [Abstract] [Full Text] [Related]
3. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
4. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
[TBL] [Abstract] [Full Text] [Related]
5. A prognostic biomarker NRG1 promotes U-87 MG glioblastoma cell malignancy by inhibiting autophagy via erbb2/AKT/mTOR pathway.
Lin JZ; Lin N; Zhao WJ
J Cell Biochem; 2023 Sep; 124(9):1273-1288. PubMed ID: 37450666
[TBL] [Abstract] [Full Text] [Related]
6. Chimeric Antigen Receptor T cells in Glioblastoma-Current Concepts and Promising Future.
Kringel R; Lamszus K; Mohme M
Cells; 2023 Jul; 12(13):. PubMed ID: 37443804
[TBL] [Abstract] [Full Text] [Related]
7. Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma.
Quddusi DM; Bajcinca N
IET Syst Biol; 2023 Aug; 17(4):143-161. PubMed ID: 37277696
[TBL] [Abstract] [Full Text] [Related]
8. Mixed mucinous adenocarcinoma/large cell neuroendocrine carcinoma of the uterine cervix: case report and molecular characterization of a rare entity.
Fattorini C; Rocca BJ; Giusti A; Arganini M; Perotti B; Cavazzana A; Ambrosio MR; Volante M
Virchows Arch; 2024 Jan; 484(1):141-146. PubMed ID: 36988712
[TBL] [Abstract] [Full Text] [Related]
9. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract] [Full Text] [Related]
10. Immune checkpoint inhibitors combined with her-2 targeted therapy in her-2 positive gastroesophageal cancer.
Aisa A; Weng S; Li X; Zhang D; Yuan Y
Crit Rev Oncol Hematol; 2022 Dec; 180():103864. PubMed ID: 36332788
[TBL] [Abstract] [Full Text] [Related]
11. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract] [Full Text] [Related]
12. Morphologic and Molecular Heterogeneity of Cervical neuroendocrine Neoplasia: A Report of 14 Cases.
Ordulu Z; Mino-Kenudson M; Young RH; Van de Vijver K; Zannoni GF; Félix A; Burandt E; Wong A; Nardi V; Oliva E
Am J Surg Pathol; 2022 Dec; 46(12):1670-1681. PubMed ID: 36069807
[TBL] [Abstract] [Full Text] [Related]
13. The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.
Shu W; Zhu X; Wang K; Cherepanoff S; Conway RM; Madigan MC; Zhu H; Zhu L; Murray M; Zhou F
Cell Oncol (Dordr); 2022 Aug; 45(4):601-619. PubMed ID: 35781872
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic Features of the tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts.
Zhang C; Zhang Y; Tan G; Mi W; Zhong X; Zhang Y; Zhao Z; Li F; Xu Y; Zhang Y
Front Immunol; 2022; 13():853074. PubMed ID: 35677045
[TBL] [Abstract] [Full Text] [Related]
15. CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies.
Antonucci L; Canciani G; Mastronuzzi A; Carai A; Del Baldo G; Del Bufalo F
Front Immunol; 2022; 13():867154. PubMed ID: 35603195
[TBL] [Abstract] [Full Text] [Related]
16. CAR T cell Therapy in Primary Brain tumors: Current Investigations and the Future.
Lin YJ; Mashouf LA; Lim M
Front Immunol; 2022; 13():817296. PubMed ID: 35265074
[TBL] [Abstract] [Full Text] [Related]
17. Clinical characteristics of glioblastoma with metastatic spinal dissemination.
Chen J; Shi Q; Li S; Zhao Y; Huang H
Ann Palliat Med; 2022 Feb; 11(2):506-512. PubMed ID: 35249328
[TBL] [Abstract] [Full Text] [Related]
18. MiRNA-375 inhibits retinoblastoma progression through targeting erbb2 and inhibiting MAPK1/MAPK3 signalling pathway.
Liu L; Xiao C; Sun Q
Cutan Ocul Toxicol; 2022 Mar; 41(1):1-10. PubMed ID: 34711123
[TBL] [Abstract] [Full Text] [Related]
19. Chimeric Antigen Receptor T cells for Glioblastoma: Current Concepts, Challenges, and Future Perspectives.
Karschnia P; Teske N; Thon N; Subklewe M; Tonn JC; Dietrich J; von Baumgarten L
Neurology; 2021 Aug; 97(5):218-230. PubMed ID: 33986138
[TBL] [Abstract] [Full Text] [Related]
20. The expression and prognostic value of the epidermal growth factor receptor family in glioma.
Xu B; Huo Z; Huang H; Ji W; Bian Z; Jiao J; Sun J; Shao J
BMC Cancer; 2021 Apr; 21(1):451. PubMed ID: 33892666
[TBL] [Abstract] [Full Text] [Related]
[Next]
